Woebot Health, maker of a psychological well being chatbot, not too long ago appointed Dr. Robbert Zusterzeel as vice chairman of regulatory science and technique.
Zusterzeel involves Woebot from IQVIA, the place he served as senior director of U.S. regulatory science and technique. He’d beforehand labored on the FDA for practically 10 years.
“We consider in and have embraced regulation from the beginning and have expanded our science-based product group, which makes it the right time so as to add deep experience to speed up the method towards clearance. Robbert’s distinctive mixture of medical, scientific and regulatory expertise and keenness for this rising house might be instrumental in bringing our clinically-proven merchandise to market,” Woebot founder and president Alison Darcy stated in a press release.
In March, the startup added a $9.5 million investment from Leaps by Bayer, constructing on a $90 million Series B from July 2021. Woebot additionally acquired FDA Breakthrough Device Designation for its investigational postpartum melancholy digital therapeutic, WB001, final yr. Moreover it is engaged on a product for adolescent melancholy, dubbed WB002.
Decentralized medical trial startup Curebase named Sean Lynch as vice chairman of medical operations.
Lynch beforehand labored as senior director of medical challenge administration at tech-driven medical trial firm TrialSpark. He’d additionally served as senior director of worldwide gross sales and senior challenge supervisor at medical analysis group Syntactz.
“Sean is an skilled medical trial skilled with a robust enterprise growth background, which makes him excellent to guide our medical operations,” Curebase founder and CEO Tom Lemberg stated in a press release. “His means to arrange and encourage medical trial groups and his challenge administration coaching will drive development for the corporate whereas opening up alternatives for extra folks to take part in medical analysis.”
Earlier this yr, Curebase raised $40 million in Series B funding.
Ophelia, which gives digital remedy for opioid use dysfunction, appointed Lon Binder as chief know-how officer.
Binder most not too long ago was CTO at Cityblock Well being, a tech-enabled supplier startup aimed on the Medicaid and low-income Medicare populations. He has additionally served as CTO at vision-care and glasses retailer Warby Parker.
“Lon is an skilled know-how chief with a uncommon mixture of imaginative and prescient, creativity, coronary heart and drive,” Zack Grey, cofounder and CEO of Ophelia, stated in a press release. “We could not have discovered a greater match for our mission, tradition and crew. We’re extraordinarily proud to work with him and to construct the core know-how collectively that can energy the way forward for dependancy remedy.”
Ophelia raised two rounds of funding in 2021: a $15 million Series A introduced in April and a $50 million Series B from December.
Suki, maker of an AI-backed healthcare documentation assistant, introduced two new hires for its product crew.
Belwadi Srikanth will function vice chairman of product and design. He labored at Google for greater than 15 years, the place he labored as director of product administration.
Anmol Rastogi was named senior director of product administration. He’d beforehand served as vice chairman of merchandise at Indian on-line mortgage firm Lendingkart and as India product lead with monetary providers agency Tala.
“At Suki, we acknowledge that successful merchandise come from groups comprised of deep expertise. We wish to entice the very best within the enterprise as we goal to carry pleasure again to medication by assuaging doctor burnout,” Punit Soni, founder and CEO of Suki, stated in a press release. “These two new product leads are key appointments who’re greater than ready to offer the management that can make our product imaginative and prescient a actuality within the coming years.”
Suki most not too long ago introduced a $55 million Series C round in late 2021.
House and senior care platform Honor Technology named Andrew Steinberg as chief monetary officer.
He beforehand labored at funding banking agency Evercore, the place he was a managing director targeted on M&A and capital markets advisory in software program, AI and machine studying, medtech and journey tech.
“I’m thrilled to welcome Andrew together with his deep breadth of information to our government management crew,” Honor CEO and cofounder Seth Sternberg stated in a press release. “His alignment with Honor’s mission to develop the world’s capability to care will place us to optimize the huge alternatives we’re experiencing within the residence care market and improve our means to ship on this imaginative and prescient.”
In October, Honor introduced it had raised $70 million in a Series E round and $300 million in debt financing, incomes the corporate unicorn standing with a valuation of greater than $1.25 billion. The corporate additionally not too long ago acquired residence care supplier House As a substitute.
